Dose and Timing of the First Light Fraction in Two-fold Illumination Schemes for Topical ALA-mediated Photodynamic Therapy of Hairless Mouse Skin¶

Abstract A fractionated illumination scheme in which a cumulative fluence of 100 J cm−2 is delivered in two equal light fractions separated by a dark interval of 2 h has been shown to considerably increase the efficacy of 5-aminolevulinic acid (ALA)–photodynamic therapy (PDT). The efficacy of such a scheme is further increased if the fluence of the first light fraction is reduced to 5 J cm−2. We have investigated the relationship between the PDT response and the kinetics of protoporphyrin IX (PpIX) fluorescence in the SKH1 HR hairless mouse for first fraction fluences below 5 J cm−2 delivered 4 h after the application of ALA and 10 J cm−2 delivered 2 h after the application of ALA. Illumination is performed using 514 nm at a fluence rate of 50 mW cm−2. Reducing the fluence of the first fraction to 2.5 J cm−2 does not result in significantly different visual skin damage. The PDT response, however, is significantly reduced if the fluence is lowered to 1 J cm−2, but this illumination scheme (1 + 99 J cm−2) remains significantly more effective than a single illumination of 100 J cm−2. A first light fraction of 10 J cm−2 can be delivered 2 h earlier, 2 h after the application of ALA, without significant reduction in the PDT response compared with 5 + 95 J cm−2 delivered 4 and 6 h after the application of ALA. The kinetics of PpIX fluorescence are consistent with those reported previously by us and do not explain the significant increase in PDT response with a two-fold illumination scheme. Histological sections of the illuminated volume showed a trend toward increasing extent and depth of necrosis for the two-fold illumination scheme in which the first light fraction is 5 J cm−2, compared with a single illumination scheme.

[1]  W. Star,et al.  Photodynamic Effectiveness and Vasoconstriction in Hairless Mouse Skin after Topical 5‐Aminolevulinic Acid and Single‐ or Two‐fold Illumination , 1999, Photochemistry and photobiology.

[2]  H. S. de Bruijn,et al.  Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. , 1999, Cancer research.

[3]  C. Whitehurst,et al.  Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid‐based photodynamic therapy , 2000, The British journal of dermatology.

[4]  R. Rava,et al.  Analytical model for extracting intrinsic fluorescence in turbid media. , 1993, Applied optics.

[5]  Stanley B. Brown,et al.  Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.

[6]  E. Hull,et al.  Carbogen-induced changes in rat mammary tumour oxygenation reported by near infrared spectroscopy , 1999, British Journal of Cancer.

[7]  M G Nichols,et al.  Quantitative broadband near-infrared spectroscopy of tissue-simulating phantoms containing erythrocytes. , 1998, Physics in medicine and biology.

[8]  Alison Curnow,et al.  Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.

[9]  H. S. de Bruijn,et al.  Topical 5-Aminolevulinic Acid-photodynamic Therapy of Hairless Mouse Skin Using Two-fold Illumination Schemes: PpIX Fluorescence Kinetics, Photobleaching and Biological Effect†¶ , 2000, Photochemistry and photobiology.

[10]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.